Prosus NV (PRX.AS)

Cours de clôture: 39.98 (+0.05), 24. avr 2025
Hold

Moyen risk

Automatic technical analysis. Moyen terme, 24. avr 2025

Prosus NV fluctue dans un canal haussier, qui indique une poursuite de la croissance. La valeur a subi une baisse importante après le signal de vente de la formation rectangulaire et le franchissement à la baisse du support à 42.82. L'objectif de 40.05 est maintenant atteint, mais la formation indique une poursuite du développement dans la même direction. L'action s'approche de la résistance à environ 41.30 euro, ce qui peut indiquer qu'une correction est possible. La balance des volumes négative affaiblit la valeur sur le court terme. L'action est généralement considéré comme neutre technique pour moyen long terme.

Recommendation one to six months: Hold (Score: -18)

Période  
Vol.bal. Volatilité Liquidité +/- %
1 jour-1.42%87.38+0.14%
5 jours10.464.89%122.32+4.93%
22 jours-64.7314.05%156.98-7.97%
66 jours-37.0226.77%166.07+13.68%

More analyses of Prosus NV

chart Prosus NV (PRX) Chandeliers 22 Days
Candlesticks
chart Prosus NV (PRX) Court terme
Court terme: Conclusion légèrement négative
chart Prosus NV (PRX) Moyen terme
Moyen terme: Hold
chart Prosus NV (PRX) Long terme
Long terme : Hold
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.